Viewing Study NCT06619704


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2025-12-30 @ 2:47 AM
Study NCT ID: NCT06619704
Status: COMPLETED
Last Update Posted: 2024-10-04
First Post: 2024-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Observational Retrospective Study to Assess the Use of Ribociclib in Patients With HR+, HER2- Metastatic Breast Cancer Treated With Chemotherapy
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module